Showing results (251-260 of 271) with videos related to
Sort By:
Pageof 28
Clinical Pharmacology in Drug Development|June 17, 2016
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy VolunteersVeit J Erpenbeck, Eva Vets, Lien Gheyle, et al.Pulmonary Pharmacology & Therapeutics|June 30, 2016
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.Journal of Clinical Pharmacology|January 25, 2006
Fingolimod (FTY720) in severe hepatic impairment: pharmacokinetics and relationship to markers of liver functionJohn M Kovarik, Robert L Schmouder, Stefan Hartmann, et al.Plos One|May 2, 2015
The Induction of IL-33 in the Sinus Epithelium and Its Influence on T-Helper Cell ResponsesMichael B Soyka, David Holzmann, Tomasz M Basinski, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2017
Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In VitroDavid Pearson, H Markus Weiss, Yi Jin, et al.RMD Open|August 14, 2025
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyNan Shen, Julia Weinmann-Menke, Ana Malvar, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 15, 2012
Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitroHans-Peter Gschwind, Ulrike Glaenzel, Felix Waldmeier, et al.Cancers|November 26, 2022
Association between Intraoperative Blood Transfusion, Regional Anesthesia and Outcome after Pediatric Tumor Surgery for NephroblastomaSarah D Müller, Christian P Both, Christoph Sponholz, et al.Head & Neck|September 13, 2021
Whole-body hybrid positron emission tomography imaging yields clinically relevant information in the staging and restaging of sinonasal tumorsAlexander Maurer, Christian M Meerwein, Michael B Soyka, et al.Histopathology|June 26, 2024
Expanding the spectrum of low-grade sinonasal adenocarcinoma with biphasic seromucinous differentiation and activating HRAS/AKT1 mutationsViktoria S Hadnagy, Meike Körner, Matthias Rössle, et al.Pageof 28